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Introduction 
Gynecologic cancers are caused by uncontrolled growth and 
spread of  abnormal cells originating in the female reproductive 
organs, including the cervix, ovaries, uterus, fallopian tubes, va-
gina and vulva. Over one million gynecologic cancers have been 
diagnosed in women worldwide and almost half  have resulted in 
death [1]. This review describes the current evidence regarding 
modifiable lifestyle factors and the risk of  gynecological cancer, 
with a focus on the three main types of  gynecologic cancer: en-
dometrial, ovarian and cervical, which are among the top seven 
causes of  cancer incidence and deaths among women [2].
Methods
This focus of  this review was limited to the following modifiable 
lifestyle risk factors of  endometrial, ovarian and cervical cancer: 
obesity, physical activity, diet, and smoking. Risk factors related 
to medications, medical procedures and parity were not explored 
for the purpose of  this review. In order to review the evidence on 
lifestyle factors and the risk of  gynecological cancer, we conduct-
ed a search of  the Pubmed/Medline database, which comprises 
millions of  citations from the biomedical literature, life science 
journals, and online books. Given the broad scope of  this review 
in terms of  the number of  cancers and risk factors explored, we 
primarily sought systematic reviews and meta-analysis that were 
conducted within the last 10 years (since 2004) using keywords 
that included obesity, physical activity, diet and smoking for en-
dometrial, ovarian and cervical cancers. In some cases, individual 
studies were considered, especially if  no reviews or meta-analysis 
were available for a specific topic. In order to minimize possible 
selection bias inherent in using multiple systematic reviews and 
meta-analysis (resulting in the repeated citation of  the same arti-
cles), we attempted to restrict the basis of  evidence for associa-
tions to those not containing overlapping systematic reviews and 
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meta-analyses.
Results
Review and Assessment of  the Literature
Out of  over 90 studies that were found that matched the above 
search criteria, 68 were used for this review. The evidence is pre-
sented in the following sections according to the three cancers 
reported: endometrial, ovarian and cervical. Tables 1-3 summa-
rize the evidence for the association between the various lifestyle 
factors and endometrial, ovarian and cervical cancer risk, respec-
tively.
Lifestyle Risk Factors and Endometrial Cancer
Endometrial cancer (i.e. cancer of  the lining of  the uterus) is the 
most common gynecological cancer and the fourth most com-
mon cancer for women in developed countries, accounting for 
6% of  new cancer cases among women in the United States [1, 2]. 
Lifestyle risk factors also play a prominent role in the etiology and 
development of  endometrial cancer, especially smoking, obesity, 
diet, and physical activity [3]. Lifestyle factors are often associ-
ated with Type I estrogen-dependent endometrial cancer. Type 1 
is typically associated with unopposed estrogen, a low-grade his-
tology and an endometroid histologic subtype. Type II, which is 
non-estrogen dependent and typically occurs in older women, is 
high grade, and has a serous histologic type [4, 5].
Obesity: Epidemiologic studies have consistently shown positive 
associations between obesity and endometrial cancer risk, which 
may be explained by alterations in the metabolism of  endogenous 
hormones, production of  certain cytokines, adipose-dependent 
inflammatory reactions, and genetic factors [6]. Obesity is an es-
tablished risk factor for endometrial cancer, both Type 1 and Type 
2, with an increased risk of  approximately 50% for every 5-unit 
increase in body mass index (BMI), especially for women who 
have never used hormone replacement therapy (HRT) [7, 8]. A re-
cent review and meta-analysis identified 12 published manuscripts 
on obesity and endometrial cancer survival, 4 of  which suggested 
that obesity assessed by BMI at diagnosis is associated with worse 
survival among women diagnosed with endometrial cancer, with 
risk ratios (RR) ranging from 1.86–2.76 for women with a BMI 
≥40 kg/m2 compared with non-obese weight women [9]. Obese 
women with endometrial cancer have also displayed higher mor-
tality, which may be due to obese women being more likely to 
miss routine cancer screening that results in delayed diagnosis and 
poorer prognosis [10].
The strongest associations have been observed for adult weight 
gain and current adiposity, but those who lost weight have also 
been found to be at decreased risk [11-13]. The World Cancer 
Research Fund/American Institute for Cancer Research (WCRF/
AICR) 2013 Continuous Update Project rated the strength of  the 
overall evidence on obesity as a causal factor in endometrial can-
cer development as “convincing” [8].
Physical Activity: Another potentially modifiable risk factor 
related to obesity is physical activity, which regulates hormonal 
and metabolic pathways and helps control body weight, and 
thus may protect against endometrial cancer [14]. Several stud-
ies have shown a link between physical activity and endometrial 
cancer risk. Women who performed 90 min/day or more of  non-
occupational physical activity had decreased endometrial cancer 
risk (RR, 0.54; 95% confidence interval (CI), 0.34-.85) compared 
to those who exercised less than 30 min/day [15]. A population-
based case control study found that women who reported 7.5 
metabolic equivalent (MET)-hours per week had a 34% lower 
endometrial cancer risk (OR, 0.66; 95% CI:0.50-0.87) compared 
to women who had 0 MET-hours/week, after adjusting for risk 
factors, including BMI. Also, women who sat > 8 hours/day had 
a 52% increased odds of  endometrial cancer (OR, 1.52; 95% 
CI:1.07-2.16) compared to those who sat < 4 hours/day [9]. The 
European Prospective Investigation into Cancer and Nutrition 
Study (EPIC), however, found no protective effect of  physical 
activity and endometrial cancer risk, with a limited benefit among 
postmenopausal women [16].
Table 1.  Summary of  evidence for associations between lifestyle factors and endometrial cancer risk1.
Factor Evidence of  Association2
Obesity Strong Evidence of  Increased Risk
Physical Activity Moderate to Strong Evidence of  Increased Risk
Diet Suggestive Evidence, Overall
High Fruit and Vegetable Intake Suggestive Evidence of  Mildly to Moderately Decreased Risk
High Total Alcohol Intake Insufficient Evidence, Overall
High Intake of  Dairy Products Suggestive Evidence, Overall
High Intake of  Dietary Fat, Cholesterol and Egg Suggestive Evidence, Overall
High Intake of  Coffee Suggestive Evidence of  Mildly to Moderately Decreased Risk
High Intake of  Green Tea Suggestive Evidence, Overall
High Glycemic Intake Suggestive Evidence of  Mildly to Moderately Decreased Risk
High Intake of  Isoflavones Suggestive Evidence of  Mildly to Moderately Decreased Risk
Tobacco Smoking Moderate to Strong Evidence of  Decreased Risk
Strong Evidence of  Decreased Risk Among Postmenopausal Women
1 Table 1 summarizes only associations with endometrial cancer incidence; associations between  factors and screening, premalignant 
lesion risk, and mortality risk are not shown.
2 Insufficient evidence=lack of  studies to make conclusions; Suggestive evidence=some studies support but overall inconsistent; 
Moderate=evidence supports but some inconsistencies; Strong=overall evidence is consistent and shows strong associations.
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Two meta analysis have shown approximately 20–30% significantly 
reduced risks of  endometrial cancer for the most active versus 
least active women [17, 18]. A recent meta-analysis attempted to 
quantify the dose-response relationship and observed that an in-
crease in leisure-time physical activity may continue to decrease 
endometrial cancer risk, within the range of  0–50 MET-hours/
week or 0–15 hours/week [14]. More prospective studies are 
needed to assess the magnitude of  risk reduction and to deter-
mine which aspects of  physical activity contribute to reduced risk, 
and during which period of  life physical activity is more effective 
in changing endometrial cancer risk [18]. The WCRF Continuous 
Update Project rated the overall evidence for physical activity and 
decreased endometrial cancer risk as “probable” [8].
Diet: The evidence regarding endometrial cancer and diet has not 
been consistent [10]. Although results from case control studies 
have shown that foods high in fat and cholesterol (e.g. red meat, 
margarine and eggs) were positively associated with endometrial 
cancer, evidence from large prospective studies have not always 
supported these results, especially in postmenopausal women [10, 
19-22]. Evidence on phytoestrogens shows that isoflavones may 
reduce the risk of  endometrial cancer, especially in non-obese 
women who consume large quantities compared to obese women 
who consume small amounts of  phytoestrogens [23]. Other di-
etary factors that may decrease endometrial cancer risk include 
crude and dietary fiber, non-starch polysaccharides, and vitamins 
Table 2.  Summary of  evidence for associations between lifestyle factors and ovarian cancer risk1
Factor Evidence of  Association2
Obesity Limited Evidence, Overall
Suggestive Evidence of  Mildly to Moderately Increased Risk Among Young 
Adult and/or Premenopausal Women
Physical Activity Suggestive Evidence of  Mildly to Moderately Decreased Risk 
Diet Insufficient Evidence, Overall
High Fruit and Vegetable Intake Suggestive Evidence of  Mildly to Moderately Decreased Risk
High Total Alcohol Intake Suggestive Evidence of  Mildly to Moderately Decreased Risk
High Intake of  Dairy Products Insufficient Evidence, Overall
High Intake of  Dietary Fat, 
Cholesterol and Egg
No Known Association, Overall
Tobacco Smoking Strongly Increases Risk of  Mucinous Subtype
Suggestive Evidence of  Mildly to Moderately Increased Risk of  Clear Cell 
Subtype
1 Table 2 summarizes only associations with ovarian cancer incidence; associations between lifestyle factors and screening, premalignant 
lesion risk, and mortality risk are not shown.
2 Insufficient evidence=lack of  studies to make conclusions; Suggestive evidence=some studies support but overall inconsistent; 
Moderate=evidence supports but some inconsistencies; Strong=overall evidence is consistent and shows strong associations.
Table 3.  Summary of  evidence for associations between lifestyle factors and cervical cancer risk1
Factor Evidence of  Association2
Obesity Suggestive Evidence, Overall
Moderately Increases Adenocarcinoma Risk
No Known Association, Squamous Cell Carcinoma Risk
Physical Activity Insufficient Evidence
Diet Insufficient Evidence, Overall
High Intake of  Carotene (including beta-
carotene)
Suggestive Evidence of  Moderately Decreased Risk
High Intake of  Folic Acid Suggestive Evidence of  Moderately Decreased Risk
High Intake of  Calcium Insufficient Evidence, Overall
High Intake of  Antioxidants Insufficient Evidence, Overall
High Intake of  Long-chain Polyunsatu-
rated Fatty Acids
Insufficient Evidence, Overall
Multivitamin/Mineral Supplementation Insufficient Evidence, Overall
High Intakes of  Fruits and Vegetables Suggestive Evidence of  Mildly to Moderately Decreased Risk
Tobacco Smoking Strongly Increases Risk
1 Table 3 summarizes only associations with cervical cancer incidence; associations between lifestyle factors and screening, premalig-
nant lesion risk, and mortality risk are not shown.
2 Insufficient evidence=lack of  studies to make conclusions; Suggestive evidence=some studies support but very inconsistent; 
Moderate=evidence supports but inconsistencies remain; Strong=overall evidence is consistent and shows strong associations
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A and C [24, 25]. Recent dietary evidence has shown conflicting 
evidence for vitamin D, with a few case-control studies show-
ing possible associations [26], but a recent large prospective study 
showing no effect [27]. Dietary fiber, retinol, beta-carotene, vita-
min C, vitamin E, and vitamin supplementation may decrease the 
risk of  endometrial cancer [28]. The 2013 WCRF/AICR Con-
tinuous Update report rated the evidence for most of  the above 
nutrients as “limited-no conclusion” [8].
Decreased risk of  endometrial cancer has also been shown for 
whole grains [24] and fruits and vegetables [29]. One review paper 
suggested a modest inverse association with vegetable consump-
tion, especially cruciferous vegetables (summary ORs were 0.90 
(CI, 0.86-0.95) for total vegetables and 0.79 (CI, 0.69-0.90) for 
cruciferous vegetables, respectively [29], but two large prospec-
tive studies did not support associations between fruit and veg-
etable consumption and endometrial cancer [29, 30]. More large 
controlled trials and prospective studies are needed to adequately 
assess the effects of  several dietary factors on endometrial cancer 
risk [10]. The 2013 WCRF/AICR Project Report for endometrial 
cancer reported ‘sufficient’ evidence regarding a probable causal 
relationship with increasing glycemic load [8]. However, the sug-
gestive inverse association with non-starchy vegetables and posi-
tive association with red meat reported in the 2007 report [31] 
were not confirmed in the 2013 update, which only considered 
prospective studies.
There has also been considerable interest in the relationship be-
tween coffee and tea drinking and cancer risk because tea, es-
pecially, is a rich source of  antioxidant polyphenols. The 2013 
WCRF/AICR report concluded there was now sufficient evidence 
to suggest a probable inverse relation between coffee consump-
tion and risk of  endometrial cancer, but that there was insufficient 
evidence regarding tea [8]. Je et al. observed a pooled RR of  endo-
metrial cancer for the highest versus lowest categories of  coffee 
intake was 0.71 (95% CI: 0.62-0.81) [32]. A recent prospective 
study and meta-analysis found no association between tea and en-
dometrial cancer risk, but coffee showed a slight decrease in risk 
[33]. Although green tea has been associated with reduced risks 
of  endometrial cancer, additional data from prospective studies 
are needed [34].
Smoking: Smoking has consistently shown an inverse relation-
ship with endometrial cancer risk [3, 35, 37]. A large prospective 
study recently showed that current and former smokers who re-
cently quit had significantly lower endometrial cancer risks com-
pared to never smokers [38]. A previous meta-analysis of  pro-
spective and case-control studies showed that cigarette smoking 
was associated with a reduced risk of  endometrial cancer among 
current (RR, 0.65; 95 % CI, 0.55, 0.78) and former smokers (RR, 
0.89; 95 % CI, 0.80-1.00) compared to never smokers, especially 
among postmenopausal women [35]. Quitting smoking 1–4 years 
prior to baseline was significantly associated with endometrial car-
cinoma risk (RR, 0.65; 95 % CI, 0.48-0.89), while quitting 10 or 
more years before baseline was not [35].
The relative risk of  endometrial cancer has been reported to be 
approximately 0.5 in smokers [39], with a stronger decrease in risk 
observed in postmenopausal women. In addition, the longer and 
heavier the duration of  smoking, the less the risk for developing 
endometrial cancer. This association does not appear to be true 
for passive smokers [40]. The biologic mechanism for these find-
ings may be due to the anti-estrogenic effects of  smoking [36, 38].
Smokers have shown a lower risk of  developing endometrial or 
clear cell ovarian cancers, a pattern that is consistent with the pre-
viously reported inverse association between smoking and risk of  
endometrial cancer [36]. This somewhat surprising observation 
has been attributed to the fact that smokers tend to have lower 
circulating estrogen levels and earlier menopause than nonsmok-
ers [41].
Lifestyle Risk Factors and Ovarian Cancer
The majority of  ovarian cancers either begin in the cells on the 
surface of  the ovary (i.e., epithelial ovarian cancer) or in egg cells 
(i.e., malignant germ cell tumors). Given the lack of  efficacy of  
ovarian cancer screening, most women are diagnosed at an ad-
vanced stage, for which curative treatment is often unavailable 
[42]. Of  the gynecological cancers, epithelial ovarian cancer is 
the most common cause of  cancer-related deaths and the fourth 
most common cause of  cancer-related morbidity among women 
[42]. Although factors such as family history of  or an inherited 
predisposition (e.g., BRCA1 or BRCA2 mutation) to ovarian can-
cer increase a woman’s risk of  developing ovarian cancer that can-
not be modified, there are lifestyle risk factors that can potentially 
be modified to reduce ovarian cancer risk [43].
Obesity: There is limited evidence to suggest obesity is associ-
ated with a small to moderately increased risk of  ovarian can-
cer among young adult and/or premenopausal women [44, 45]. 
Olsen et al. conducted a meta-analysis of  25 studies, for which 
the pooled effect estimate for obesity versus normal BMI was 1.3 
(95% CI:1.1-1.5) [45]. Using data from five case control studies 
and four cohort studies that reported on BMI in young adult-
hood, the pooled effect estimate was 1.22 (95% CI:1.02–1:45). 
Of  three case–control studies and one cohort study that strati-
fied by menopausal status, three studies reported higher risk 
estimates associated with elevated BMI among premenopausal 
women [45]. A pooled analysis of  12 prospective cohort stud-
ies did not find a significant association between baseline obesity 
and ovarian cancer risk among women overall (pooled RR, 1.03; 
95% CI:0.86-1.22) or among women in early adulthood (pooled 
RR, 1.01; 95% CI:0.72-1.43) [44]. However, baseline obesity was 
positively associated with ovarian cancer risk in premenopausal 
women (pooled RR, 1.72; 95% CI:1.02-2.89), although the num-
ber of  premenopausal cases was limited. Both reviews noted that 
the studies reviewed often lacked sufficient statistical power to 
detect modest effects by histological subtypes of  ovarian cancer 
and acknowledged limitations in using a single BMI measurement 
[44, 45]. Weight change during follow-up may attenuate the risk 
estimates and Schouten et al. found cases with longer follow-up 
were more likely to be postmenopausal at diagnosis than those 
with a shorter follow-up, further suggesting a time-dependent as-
sociation. The 2013 WCRF/AICR Continuous Update Project 
rated the evidence for obesity and increased ovarian cancer risk 
as “probable ” [8].
Physical Activity: Some evidence suggests recreational physical 
activity is associated with a small to moderately decreased risk of  
ovarian cancer, but research findings regarding this relationship 
lack consistency [46, 47]. Olsen et al. conducted a meta-analysis 
of  twelve case-control and cohort studies targeting the asso-
ciation between recreational physical activity and histologically 
confirmed ovarian cancer [46]. For the case control studies, the 
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pooled RR for the risk of  ovarian cancer associated with high-
est versus lowest levels of  recreational physical activity was 0.79 
(95% CI:0.70-0.85). The pooled RR was 0.81 (95% CI:0.57-1.17) 
for the six cohort studies and 0.72 (95% CI:0.53-0.98) upon ex-
clusion of  a study with outlying results. The pooled results of  
this meta-analysis suggest that recreational physical activity level 
is inversely associated with ovarian cancer risk [46]. However, in 
a meta-analysis of  cohort and case-control studies on the asso-
ciation between any form of  physical activity and ovarian can-
cer risk, Cust reported one study with a positive association, half  
observed no association and the remainder reported inverse as-
sociations. Among the studies observing an inverse association 
between physical activity and ovarian cancer risk, dose-response 
relationships were not consistently found across physical activity 
categories [47]. For example, Rossing et al. observed a statistically 
significant inverse dose-response relationship between increasing 
duration of  high-intensity recreational activity and ovarian cancer 
risk, but not for duration of  total recreational physical activity, 
low-or moderate-intensity activity, or MET-hours per week of  
recreational activity [48]. Given the inconsistencies in the current 
literature, additional observational research is needed to elucidate 
the relationship between different forms of  physical activity and 
ovarian cancer risk. The 2013 WCRF/AICR report rated the evi-
dence on physical activity as “limited-no conclusion” [8].
Diet: The evidence from several reviews of  diet and ovarian can-
cer does not support consistent relationships between moderate 
intake of  dietary factors, including fruit and vegetables, alcohol, 
dairy products, calcium, fat and cholesterol, and increased risk of  
ovarian cancer [49-53]. For example, Koushik et al. conducted a 
pooled analysis of  data from 12 prospective studies over 7 to 22 
years of  follow-up in which fruit and vegetable intake was meas-
ured at baseline using a validated food frequency questionnaire 
(FFQ). The pooled RR for the highest versus the lowest quar-
tile of  fruit and vegetable intake was 1.06 (95% CI:0.92-1.21) and 
0.90 (95% CI:0.78-1.04), respectively, and findings were similar 
across histologic subtypes [49]. Similarly, Genkinger et al. con-
ducted a pooled analysis of  data from 10 prospective cohort stud-
ies on 529, 638 women with 2,001 incident epithelial ovarian cases 
for which the pooled RR comparing ≥ 30 to 0 g per day of  total 
alcohol and risk of  ovarian cancer was 1.12 (95% CI:0.86–1.44) 
[53]. As other reviews on dairy products and ovarian cancer have 
noted, it is important for future research to take dietary guidelines 
into account since a lactose intake equivalent to three or more 
servings of  milk per day was associated with a modest increase 
in ovarian cancer risk, and three servings were recommended by 
newly released guidelines [52]. One limitation of  the prospective 
studies reviewed is that baseline FFQs tended to capture dietary 
intake for the year preceding the start of  the follow-up period, so 
it was not possible to account for changes in intake during follow-
up [52]. The 2013 WCRF/AICR report rated the dietary evidence 
for ovarian cancer risk as “limited-no conclusion ”[8].
Smoking: Although previous research suggested smoking was 
not associated with an increased risk of  ovarian cancer, there 
is emerging evidence that smoking is positively associated with 
the mucinous histological subtype of  ovarian cancer in a dose-
response manner and that this relationship can be reversed upon 
smoking cessation [54]. Jordan et al. conducted a systematic lit-
erature review and meta-analysis of  eight population-based case–
control studies, one pooled analysis of  case–control studies, and 
one cohort study that included a total of  6,474 persons, 910 of  
whom had a mucinous ovarian cancer diagnosis, and 5,564 of  
whom had non-mucinous ovarian cancer diagnosis. Comparing 
current smokers to never smokers, the risk of  mucinous ovarian 
cancer doubled significantly (pooled RR, 2.1; 95% CI:1.7–2.7), the 
risk of  serous (pooled RR, 1.0; 95% CI:0.8–1.2) and endometri-
oid (pooled RR, 0.8;  95% CI:0.6–1.1) cancers were similar, and 
the risk of  clear cell ovarian cancers were reduced significantly 
(pooled RR, 0.6; 95% CI:0.3–0.9) [54]. Furthermore, although the 
risk of  mucinous cancer increased with increasing smoking levels, 
it returned to that of  never smokers within 20–30 years of  smok-
ing cessation [54].
Lifestyle Factors and Cervical Cancer
Cervical cancer forms in the cervix and usually develops very 
slowly and without symptoms. Cervical cancer is one of  the most 
preventable cancers, and, therefore, has lower incidence, since it 
can be identified through regular Pap tests (a procedure in which 
cervical cells are scraped and microscopically examined) [55]. 
HPV is the primary etiologic agent of  cervical cancer, which al-
most never occurs without HPV infection. As a result, risk factors 
for cervical cancer are normally associated with, either directly or 
indirectly, the process of  HPV-associated cervical cancer carcino-
genesis [55]. Therefore, it should be noted that each risk factor 
to be described is potentially associated with HPV transmission, 
infection, and/or progression to cervical cancer or a precancer-
ous lesion.
Obesity: Results from a review of  studies suggest no consistent 
evidence for the association between obesity and cervical cancer 
incidence [56]. However, some results suggest a moderately in-
creased cervical adenocarcinoma risk (as opposed to squamous 
cell carcinoma risk) among obese women [56]. In a matched case-
control study, Lacey et al. reported that obese women (versus nor-
mal weight women) were at increased risk of  cervical adenocar-
cinoma (OR, 2.1; 95% CI:1.1-3.8) and that women in the highest 
versus lowest tertile of  waist-to-hip ratio were also at increased 
risk (OR, 1.8; 95% CI:0.97-3.3), while results pertaining to squa-
mous cell carcinoma were weaker and not statistically significant 
[57]. Cervical adenocarcinoma, representing approximately 15 
percent of  cervical cancers, may be more hormonally responsive 
than squamous cell carcinoma and may exhibit a “mitogenic ef-
fect of  increased estrogen on glandular cervical cancers.” [56] 
Published studies on possible molecular mechanisms have shown 
that alterations in the endogenous hormone profiles, production 
of  specific adipose proteins, cytokines and inflammation, and 
intrinsic genetic factors may play roles in the development and 
progression of  cervical cancer [6]. Cervical cancer mortality risk is 
also increased among obese women [56, 58-60], which may result 
from the fact that obese women are less likely to be compliant 
with HPV screening (i.e. Pap testing) recommendations [56, 59, 
61, 62]. Based on a meta-analysis, compared to normal BMI wom-
en, OR (95% CI) for Pap testing were 0.91 (0.80-1.03), 0.81 (0.70-
0.93), 0.75 (0.64-0.88), and 0.62 (0.55-0.69) for the overweight and 
class I, II, and III obesity categories, respectively [59]; although, 
these findings were apparent only for white women [59, 60]. An-
other literature review suggested an inverse association between 
decreased Pap testing and increasing body size, and, again, sev-
eral studies reported significant associations among white women 
only [61]. The 2007 WCRF/AICR report rated the evidence on 
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obesity as  “limited-no conclusion” [8].
Physical Activity: There is currently insufficient evidence con-
cerning the potential role of  physical activity in the development 
of  cervical cancer [47, 58]. It is possible that physical activity im-
pacts cervical intraepithelial neoplasias (CIN) or cervical carcino-
genesis through hormonal and/or immune function but few stud-
ies have been conducted. Lee et al. [63] found that, compared to 
women with lower levels of  leisure-time physical activity (< 38.5 
MET-hours/week), women with higher levels (>73 MET hours/
week) had significantly lower risk of  both CIN2/3 (OR, 0.58; 
95% CI:0.36-0.93) and invasive cervical cancer (OR, 0.61; 95% 
CI:0.38-0.98), even after adjustment for other factors. Additional 
studies are needed to examine the relationship between physical 
activity and cervical cancer risk. No ratings have been provided 
for physical activity from the 2007 or 2013 WCRF/AICR reports.
Diet: Overall, there are few consistent associations between di-
etary factors and cervical cancer risk from large, well-designed 
observational studies or randomized controlled trials. Dietary fac-
tors may serve as cofactors in cervical carcinogenesis, but the evi-
dence is inconclusive [31]. Because HPV infection is a necessary 
cause of  cervical cancer and since CIN is a premalignant lesion in 
the natural history of  cervical cancer, Chih et al. reviewed stud-
ies of  the dietary prevention of  both HPV infection and CIN, 
reporting that high levels of  dietary intakes of  fruits and vegeta-
bles protect against CIN, and dietary intakes of  some nutrients 
(especially those with high antiviral and antioxidant potential) may 
prevent progression of  transient and persistent HPV infections to 
high-grade CIN/in situ cervical cancer [64]. They report that high 
intake of  “retinol and vitamin A, bioavailable calcium, antioxi-
dants (including vitamin C, E, carotene, lutein and lycopene), as 
well as long-chain polyunsaturated fatty acids can significantly re-
duce the risk of  in situ cervical cancer” [64]. Results from a large 
European prospective study of  almost 300,000 women, suggested 
a statistically significant inverse association of  invasive squamous 
cervical cancer with a daily increase in intake of  100 grams of  
total fruits (HR, 0.83; 95% CI:0.72–0.98) and non-significant as-
sociations with total vegetables and most other foods, including 
beta-carotene, vitamin D, and folic acid (which had each been 
suggested as protective from previous studies) [65]. In a meta-
analysis of  22 case-control studies and over 10,000 participants, 
Myung et al. reported statistically significant associations between 
cervical neoplasia and intakes of  vitamin B12 (RR, 0.35; 95% 
CI:0.19–0.63), vitamin C (RR, 0.67; 95% CI:0.55–0.82), vitamin E 
(RR, 0.56; 95% CI:0.35–0.88), and beta-carotene (RR, 0.68; 95% 
CI:0.55–0.84), while for multivitamin and mineral supplements, 
no reduction in cancer incidence was observed [66]. Results from 
another meta-analysis based on 12,000 participants revealed asso-
ciations between cervical cancer risk and dietary intakes of  retinol 
(OR, 0.80; 95% CI:0.64–1.00), carotene (OR, 0.51; 95% CI:0.35–
0.73) and other carotenoids (OR, 0.60; 95% CI:0.43–0.84) [67]. 
While some evidence exists for fruits and vegetables and the com-
plex relationship between folic acid, its metabolism and cervical 
cancer carcinogenesis, further study is warranted due to the lack 
of  consistency of  the evidence. The WCRF/AICR 2007 report 
rated carrots as having ”probable” evidence of  decreased ovarian 
cancer risk, but non-starchy vegetables, fruit, milk, retinol and vi-
tamin E were all rated as “limited- no conclusion” [8].
Smoking: Smoking increases cervical cancer risk, although the 
mechanism in cervical carcinogenesis is not fully understood. 
Among HPV-infected women, current and former smokers have 
approximately two to three times the risk of  high-grade CIN or 
invasive cancer [68]. Current smoking increases squamous, but 
not adenocarcinoma, cervical cancer risk up to three-fold with 
increasing cigarettes smoked per day [69].
Discussion
The evidence cited in this review confirms that several modifi-
able lifestyle risk factors play a prominent role in the develop-
ment of  endometrial, cervical and ovarian cancer. In particular, 
the risk factors of  obesity, physical activity, and tobacco smoking 
have been shown to affect each of  these cancers differentially. 
Although few of  these factors have been identified as demon-
strating conclusive evidence of  increased or decreased risk, such 
as obesity and increased endometrial cancer risk, it is believed that 
enough evidence has been shown to provide suggestions for pre-
vention and management of  these cancers, as described in the 
following section.
Opportunities for Prevention and Management
As shown in Tables 1-3, smoking is strongly associated with ovar-
ian and cervical cancer risk (in addition to many other cancers), 
but protective of  endometrial cancer risk, although it decreases 
survival and results in worse outcomes [3, 70]. Due to its overall 
adverse effects on cancer risk and mortality, a reduction in the 
prevalence of  smoking should be a public health priority. Al-
though smoking rates have declined in the last decade, more ef-
forts should be made to further reduce them.
Obesity showed the strongest evidence for increased endometrial 
cancer risk, but only showed positive associations for selected 
subgroups for ovarian cancer, and selected cancer subtypes for 
cervical cancer. Given that obesity is also associated with reduced 
survival for many cancers, the reduction of  obesity is another pri-
mary target for cancer prevention and management [6, 70].
Although dietary factors and physical activity varied the most with 
regards to cancer risk for the various gynecological cancers, it is 
well known that a healthy diet and increased physical activity are 
integral for reducing obesity, and, therefore, individuals should 
be encouraged to adopt these behaviors, especially for reducing 
endometrial cancer risk, which appeared to have the strongest as-
sociation.
In addition, lifestyle risk factors may impact the success of  treat-
ment, mortality risk, and survival probability of  gynecological 
cancers. Indeed, for example, endometrial and cervical cancer sur-
vivors who are obese (BMI > 30) and use tobacco have reduced 
probabilities of  survival [6]. It is likely that other deleterious 
health factors may directly impact survival probability, although 
more research is needed in this area.
Limitations
This review primarily summarized systematic reviews and meta-
analysis conducted within the last 10 years (since 2004) regard-
ing the association between modifiable lifestyle risk factors and 
uterine, ovarian, and cervical; individual studies were cited when 
the evidence for a specific topic was sparse. This approach was 
necessary due to the broad scope of  this topic, and although it 
was an efficient way to gather the most up-to-date evidence, the 
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review of  “systematic reviews and meta-analysis” can amplify se-
lection bias inherent in the published meta-analysis and system-
atic reviews. In addition, some of  the early and/or key findings 
may have been given greater weight in this manuscript because 
they could have been included in several different reviews and/
or meta-analysis, although we sought to include non-overlapping 
reviews and to cite individual studies only when reviews or meta-
analysis were not available.
Strengths
One of  the primary strengths of  this study is that it synthesizes 
the more recent evidence (within the last 10 years) on modifiable 
lifestyle risk factors and endometrial, cervical and ovarian cancer. 
The paper also provides a discussion of  several strategies for the 
prevention and management of  gynecological cancer based on 
the information obtained from this review, which can be used to 
help develop and target prevention programs for reducing these 
gynecologic cancers.
Conclusion
Lifestyle risk factors play a prominent role in the development 
of  gynecological cancers and may also impact disease progres-
sion and survival. Although smoking and obesity emerged as the 
strongest risk factors, further research in the form of  high quality 
prospective studies and randomized trials is needed to confirm 
the results for several risk factors, especially diet and physical ac-
tivity, and for various populations and subgroups. Women should 
be educated on how modifiable lifestyle factors and associated 
behaviors may reduce their risk of  several gynecological cancers. 
Clinicians should also be made aware of  how they can assist pa-
tients in implementing risk-reducing behaviors and help survivors 
better manage their diseases.
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